Abstract
· WHO estimates up to 330 million people worldwide (4% of world population) have chronic ear infections with a significant proportion of these suffer from disabling hearing loss.
· The majority of people with treatable ear diseases reside in low‐ and middle‐income countries where access to otoscopes is limited.
· A novel, low‐cost, LED‐illuminated, solar‐powered otoscope, the Arclight has been developed as a practical and economical alternative to traditional and more expensive devices.
· In comparison with a traditional otoscope, the Arclight has been shown in our study to be equally effective in identifying common ear conditions.
· By overcoming the barriers to acquisition and maintenance of a conventional otoscope in low‐resource settings, the Arclight has potential to assist in reduction in chronic ear diseases and the subsequent hearing loss in LMICs.
| Original language | English |
|---|---|
| Number of pages | 4 |
| Journal | Clinical Otolaryngology |
| Early online date | 18 Jul 2019 |
| DOIs | |
| Publication status | E-pub ahead of print - 18 Jul 2019 |
Fingerprint
Cite this
}
A mixed methods comparative evaluation of a low cost otoscope (Arclight) with a traditional device in twenty-one clinicians. / Hey, Shi Ying (Lead / Corresponding author); Buckley, Joanna C.; Shahsavari, Somayyeh; Kousha, Obaid; Haddow, Kerry A.; Blaikie, Andrew; Walker, Frank David Lathangie.
In: Clinical Otolaryngology, 18.07.2019.Research output: Contribution to journal › Letter
TY - JOUR
T1 - A mixed methods comparative evaluation of a low cost otoscope (Arclight) with a traditional device in twenty-one clinicians
AU - Hey, Shi Ying
AU - Buckley, Joanna C.
AU - Shahsavari, Somayyeh
AU - Kousha, Obaid
AU - Haddow, Kerry A.
AU - Blaikie, Andrew
AU - Walker, Frank David Lathangie
N1 - This article is protected by copyright. All rights reserved.
PY - 2019/7/18
Y1 - 2019/7/18
N2 - Keypoints· WHO estimates up to 330 million people worldwide (4% of world population) have chronic ear infections with a significant proportion of these suffer from disabling hearing loss.· The majority of people with treatable ear diseases reside in low‐ and middle‐income countries where access to otoscopes is limited.· A novel, low‐cost, LED‐illuminated, solar‐powered otoscope, the Arclight has been developed as a practical and economical alternative to traditional and more expensive devices.· In comparison with a traditional otoscope, the Arclight has been shown in our study to be equally effective in identifying common ear conditions.· By overcoming the barriers to acquisition and maintenance of a conventional otoscope in low‐resource settings, the Arclight has potential to assist in reduction in chronic ear diseases and the subsequent hearing loss in LMICs.
AB - Keypoints· WHO estimates up to 330 million people worldwide (4% of world population) have chronic ear infections with a significant proportion of these suffer from disabling hearing loss.· The majority of people with treatable ear diseases reside in low‐ and middle‐income countries where access to otoscopes is limited.· A novel, low‐cost, LED‐illuminated, solar‐powered otoscope, the Arclight has been developed as a practical and economical alternative to traditional and more expensive devices.· In comparison with a traditional otoscope, the Arclight has been shown in our study to be equally effective in identifying common ear conditions.· By overcoming the barriers to acquisition and maintenance of a conventional otoscope in low‐resource settings, the Arclight has potential to assist in reduction in chronic ear diseases and the subsequent hearing loss in LMICs.
UR - http://www.scopus.com/inward/record.url?scp=85070699291&partnerID=8YFLogxK
U2 - 10.1111/coa.13403
DO - 10.1111/coa.13403
M3 - Letter
C2 - 31319018
JO - Clinical Otolaryngology
JF - Clinical Otolaryngology
SN - 1749-4478
ER -